WT | News

Discover our incredible news!

News

X
Text dummy
Text Link

Global Motion Sensor Market Size Projected To Reach USD 8.7 Billion By 2025

Technologies such as Virtual Reality (VR) and Augmentative Reality (AR)

The global motion sensor market size is projected to touch USD 8.7 billion by 2025. The market is anticipated to grow at 7.8% CAGR, according to a new report by Million Insights. The growing use of motion sensors in gaming devices and consumer electronics is driving the market growth. Rapidly increasing consumer electronics market is positively affecting the market growth. For example, newly introduced wearable devices are gaining traction among consumers.

Read more Global E-compass Market Is Expected To Grow At A CAGR of 14% From 2019 to 2024

Technologies such as Virtual Reality (VR) and Augmentative Reality (AR) are increasingly getting popular in consumer electronics. These technologies are incorporated in smartphones and wearable devices such as VR glass, smart glass, head-up display and VR motion chairs. Motion sensors play a crucial role in the development of VR and AR applications. The number of VR users has increased from 1 million in 2014 to 150+ million in 2018. Thus, growing VR application is expected to create a lucrative opportunity for the market players, says a press release.

For AR/VR domain, motion sensors are used for gaming applications. Motion gaming system enables players to interact with the help of body movements. The demand for interactive games has increased significantly over the last few years, thereby, supporting the growth of motion sensors.

Europe held the largest share in the motion sensors market and the region is projected to maintain its dominance over the next few years. Presence of leading automobile giant in the region is driving the growth of the market. On the other hand, Asia Pacific is anticipated to register the fastest CAGR over the forecast duration.

Further key findings from the report suggest:

  • Asia Pacific is a key market for consumer electronics and thereby, projected to occupy a significant share in the market over the forecast duration.
  • The microwave category is predicted to exhibit a significant growth rate as they can operate in the K-band frequency range.
  • Healthcare segment is projected to grow considerably owing to the increasing demand for wireless body area networks.
  • Leading players operating in the market are Kionix, Inc., NXP Semiconductors, SENSINOVA, TE Connectivity Ltd. and STMicroelectronics among others.

Million Insights has segmented the global motion sensor market based on technology, application, and region

Motion Sensor Technology Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

  • Infrared
  • Ultrasonic
  • Microwave
  • Dual Technology
  • Tomographic
  • Others

Read more Worldwide Wearable Display Market Is Forecasted To Grow At A CAGR Of 20%

Motion Sensor Application Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

  • Consumer Electronics
  • Automotive
  • Aerospace & Defense
  • Healthcare
  • Industrial
  • Others

Motion Sensor Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

North America

  • S.
  • Canada

Europe

  • Germany
  • K.

Asia Pacific

  • China
  • India
  • Japan

Central & South America

  • Brazil
  • Mexico

Middle East & Africa (MEA)

Text Link

SSIVIX Lab Rolls Out One-Stop MyCLNQ Digital Health App To Meet Healthcare Needs Digitally

Singapore-based HealthTech startup SSIVIX Lab has launched its MyCLNQ mobile app

Singapore-based HealthTech startup SSIVIX Lab has launched its MyCLNQ mobile app, which provides several key benefits to enhance the quality of life for the community. The startup has currently 15,000 users for its MyCLNQ app and plans to expand regionally in the next two years.

Read more Theranica Partners With Cove to Expand Availability of Nerivio on Cove’s Telemedicine Platform

MyCLNQ serves as a one-stop-shop to take care of all your healthcare needs smartly and digitally. Thanks to the built-in smart AI feature, you can quickly view the least waiting time at various nearby clinics located in the neighborhood and take care of your medical needs. You can also set up a digital appointment and browse for the most appropriate and available doctor to seek medical attention from.

SSVIX’s immediate focus is mainly on patient care beyond hospitals and clinics through the use of AI, IoT, and blockchain technologies. It also plans to expand regionally in India and Southeast Asian countries such as Malaysia, Indonesia, and Thailand in the coming two years, reports MobiHealthNews.

Telemedicine has allowed healthcare to be more accessible as doctors can now care for patients remotely without physical presence. You can set up a chat, video, or teleconsultation easily and consult with a doctor online in your preferred language. Especially for non-urgent cases, there is no longer a need for you to schedule an in-person visit with a doctor to receive treatment. With secure and stable video and audio connections, you can now reach doctors virtually, gain better access to care, and have your medicine delivered right to your doorstep, SSVIX Lab said on its website.

Using the built-in AI feature, you can search and filter through the results for the nearest available doctors in the neighborhood and book your appointment online. Since it’s based on location, you will be directed to the relevant clinics and doctors that are accessible and convenient by distance. The smart feature also allows you to have a bird’s eye view on the waiting times at nearby clinics and avoid the crowd for a quicker consultation.

Read more How FDA is Backing the Use of Artificial Intelligence in Telemedicine

As the leading healthcare app in Singapore, MyCLNQ is changing the way you receive healthcare. The company is focused on the MedTech industry that leverages devices which people use daily, such as smartphones, to connect all healthcare needs in one online platform.

Text Link

Noninvasive Wearable Sensors to Advance Chronic Respiratory Disease Management In Patients Around the World

The global respiratory monitoring devices market is expected to garner around 6% CAGR

According to a new report by Transparency Market Research (TMR), the global respiratory monitoring devices market is expected to garner around 6% CAGR during 2019 to 2027.

Read more Wearable Medical Devices Market to Surpass $29 Billion by 2026, According to Transparency Market Research

The popularity of non-invasive methods has helped the pulse oximeters segment climb to valuation of approximately US$ 3.4 Bn by 2027.

Research analysts at TMR assert that manufacturers in the respiratory monitoring devices market should focus on improving the effectiveness, convenience, and reliability of sensors in spirometry and capnometry. In particular, focus on innovation on flow and pressure sensors to improve management of respiratory diseases in all clinical settings, says a press release.

Key Findings of Respiratory Monitoring Devices Market Report

  • Of the various types of products, pulse oximeter segment held the leading share in 2018 in respiratory monitoring devices market
  • Of all the end-use segments, hospitals held the majority of market share in 2018
  • Home care is expected to rise at promising pace and will gain share by the end of 2027
  • Among the various key regional markets, North America accounted for the majority of share in 2018
  • Asia Pacific respiratory monitoring devices market to rise at robust CAGR of ~7% during 2019 – 2027

Respiratory Monitoring Devices Market: Key Driving Factors and Promising Avenues

  • Growing focus on respiratory health in worldwide population is a key driver for opportunities in the respiratory monitoring devices market. The prevalence and mortality of chronic obstructive pulmonary disease (COPD) and asthma is a key factor bolstering the demand for respiratory monitoring devices for diagnostic and therapeutic ends.
  • To put things in perspective, per a 2017 report by the WHO, 3 million die every year due to COPD. Further, asthma is the third leading cause of death worldwide
  • Rapidly aging population and increasing pollution levels have fueled the prospects in the respiratory monitoring devices market. According to a projection by the WHO, the geriatric population will touch 1.5 Bn by 2050.
  • Advances in performance of polysomnography have improved clinical evaluation of problems in sleep patterns, thereby boosting the respiratory monitoring devices market.
  • The growing clinical role of respiratory monitoring devices in managing sleep apnea. Over the years, sleep monitoring devices have grown in clinical relevance
  • In recent years, numerous product approvals have been made in home care segments. The application smart peak flow meters in detecting asthma exacerbations has also fueled revenues in the respiratory monitoring devices market.

Read more Fitness App Market Poised To Grow at a CAGR of 12%, Reaching 1.68 Billion During 2020-2024 Period

The Respiratory Monitoring Devices Market can be segmented as follows:

Product

  • Pulse Oximeters
  • Capnographs
  • Spirometers
  • Polysomnographs (PSG)
  • Peak Flow Meters
  • Gas Analyzers
  • Others

End User

  • Home care
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Region

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Text Link

Healthcare Organizations Using Technology To Address Health Disparities During COVID-19 Pandemic

One of the biggest health disparities comes from racial and ethnic differences

In the U.S., one of the biggest health disparities comes from racial and ethnic differences. Health disparities related to race take on many forms, including higher rates of chronic disease and premature death compared to whites.

Read more The Role Technology is Playing to Stem the Tide of COVID-19

These disparities were only made more apparent during the COVID-19 pandemic. Black, Native American Indian, and Latinx communities faced the highest rates of severe illness, according to the CDC.

Addressing Social determinants of health (SDOH) and preventing people from getting sick can be a more effective strategy than simply treating them afterward, reports MobiHealthNews.

Organizations such as NowPow and ChristianCare are focusing on SDOH by offering platforms that connect health systems, health providers and health plans to community resources.

“Long-standing systemic health and social inequities have put some members of racial and ethnic minority groups at increased risk of getting COVID-19 or experiencing severe illness, regardless of age,” the CDC said on its website.

Amid the COVID-19 pandemic, NowPow had to adjust its services for customers located in the heart of the pandemic. Some of the company’s largest networks were in New York, New Jersey and Illinois.

“We were in the thick of it, and we immediately, because we’re supporting these larger organizations, understood the magnitude of what was happening,” Kohler said.

As a result, NowPow began integrating “COVID status tags” in the platform to keep users up to date on what was opening and in what capacity.

The company also created a rapid sign-on system where a link could be sent out by text to a potential user to immediately get them registered on the platform. New emergency services popping up in the areas covered by NowPow could use the rapid sign-on to get added to the registry.

“NowPow has made it our business to know more than 45,000 community and emergency-relief services which are open and operating,” Lindau said. “So when we send people to places – people who have a real need and who find it hard to get to places under the current circumstances – those [services] are there to help them.”

Other companies, like Unite Us, which was featured in a recent HIMSS20 Digital session, have also been addressing SDOH during the pandemic.

As people begin to look past the pandemic, the need to change the way the U.S. treats healthcare has become evident, the MobiHealthNews report said.

Read more Wearables Playing Crucial Role In-Patient Monitoring During COVID-19 Pandemic

Other health organizations are focusing on legislation like the Social Determinants Accelerator Act, which would provide funding and assistance for community-based health to address SDOH.

If passed, the bill would help set up grants from the Centers for Medicare and Medicaid Services, increase coordination between health and social service programs, and set up program-evaluation criteria.

Text Link

OCBC Bank Launches Healthcare App With Partners To Provide Access To Over 100 Telehealth Doctors

OCBC Bank has partnered with seven medical groups

As Singapore enters a safe re-opening phase, OCBC Bank has partnered with seven medical groups to launch the HealthPass by OCBC mobile app, providing access to more than 100 general practitioners (GPs) and specialists. The app will address the healthcare needs of all Singapore residents over the age of 18, including non-OCBC Bank customers.

Read more How FDA is Backing the Use of Artificial Intelligence in Telemedicine

Video consultations with both GPs and specialist doctors can be booked and administered through the app, with medication delivered to the patient’s doorstep, reports OCBC.

The consultation fee is kept flat at S$20 for each telehealth and in-clinic visit to a GP during normal operating hours. Patients pay a flat fee of S$100 for the first telehealth or in-clinic consultation with any of the 63 specialist doctors from 21 specialties including gynecology, pediatrics, cardiology, dermatology and oncology, which are among the top fields of specialist medicine Singaporeans often seek medical advice for. Medication and diagnostic procedures are charged separately based on current practices.

Singapore Medical Group, one of the partners for HealthPass by OCBC, estimates that there has been a 60% surge in specialist tele-consults since the onset of COVID-19. Apart from Singapore Medical Group, the other medical partners for HealthPass by OCBC are StarMed Specialist Centre, Thomson Medical, Faith Medical Group, OneCare Medical Group, Etern Medical and True Medical.

HealthPass by OCBC integrates directly with the healthcare partner’s clinic management systems, and information is only accessible by users and their doctors, which provides personal data privacy and security. Patients can also access digital Medical Certificates (MC), clinic invoices and laboratory results from the clinics visited securely through the app. This makes it convenient for patients, especially those with on-going medical needs, to easily retrieve past records for doctor consultations without the hassle of retrieving hard copies and maintaining a physical file.

The wellness shop in the HealthPass app gives users access to more than 100 merchant offers for wellness products and services. Patients also do not need to make physical cash or card payments. Once a credit or debit card is added to the app, payments to clinics and the online store are processed digitally, and the app helps users to track all costs in one place.

Consulting a doctor through telehealth safeguards individuals more susceptible to the effects of the virus, such as the elderly, those with underlying conditions and expecting mums, allowing them to seek timely medical help with relative safety. It also helps doctors to conduct follow-up consultations with patients, especially those with chronic ailments.

Read more Vuzix M400 Smart Glasses Continue Their Expansion Into Remote Care For COVID-19 Patients

“COVID-19 will eventually pass, but its impact on the community will be long felt, and widespread access to telehealth will provide a big boost to help manage Singapore’s healthcare needs,” said Mr Pranav Seth, OCBC Bank’s Head of Digital and Innovation.

Text Link

Chugai and Biofourmis Collaborating to Develop Digital Solution For Objective Assessment of Pain

One of Japan's leading research-based pharmaceutical companies and Biofourmis

Chugai Pharmaceutical, one of Japan's leading research-based pharmaceutical companies and Biofourmis, a Boston-based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment of pain associated with endometriosis.

Read more Wearables In Combination With Digital Technology Offers Huge Opportunities For Non-Invasive Pain Management

Endometriosis is the repeated proliferation and shedding of endometrial tissue outside the uterus, accompanied by dysmenorrhea (pain with menstruation) and chronic lower abdominal pain. It is also a cause of infertility. This disease affects one out of 10 women in their 20s to 40s. The only existing medications are hormonal agents. Moreover, if the pain cannot be controlled by drugs, the only treatment is surgical removal of the endometriotic tissue, says a press release.

Pain is one of the main symptoms of endometriosis and therapeutically important. The severity of pain may vary from day to day, and it can be a major issue that affects patients' quality of life.

The Chugai-Biofourmis partnership will leverage Biofourmis' Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and artificial intelligence (AI)-based algorithms. The solution will be validated in a global, multi-center observational study enrolling more than 120 endometriosis patients.

The digital solution for managing patients with endometriosis in an ambulatory setting will include a wearable, clinical-grade biosensor to capture physiology biomarkers and a patient-facing mobile app to monitor symptoms, with a gamification engine for patient engagement. The AI-based technology will provide a continuous quantification of pain by applying analytics to physiology biomarkers. The platform will also include a clinician-facing web dashboard for remote review and intervention.

“Through the partnership with Biofourmis, a leading company in research, development and commercialization of digital therapeutics, Chugai will set out to objectively assess pain associated with endometriosis and better understand its pathology," said Satoko Shisai, Chugai's Vice President, Head of Digital & IT Supervisory Division. "Through this partnership, Chugai is demonstrating its commitment to applying the most advanced digital technologies to better understand the real-life needs of patients and to develop innovative solutions for society, as outlined in the CHUGAI DIGITAL VISION 2030.”

Read more How Femtech Companies are Helping to Make Women’s Lives Easier and More Comfortable

Kuldeep Singh Rajput, CEO and founder of Biofourmis, said: “Chugai aims to become a top innovator by utilizing digital technologies, and we are thrilled to partner with them." He added: "This unique collaboration with Chugai is another indicator of the growing consensus in the healthcare industry that combining digital solutions with therapeutic developments—from discovery to patient care—is a powerful way to augment efficiency. Digital solutions can deliver faster, more reliable insights to clinicians to aid interventions, while increasing engagement and improving outcomes for patients and lowering healthcare costs for all stakeholders."

Text Link

MIT Researchers Develop New Method of Stimulating Neurons

To manipulate neural cells, doctors and scientists routinely use two methods

To manipulate neural cells, doctors and scientists routinely use two methods – electrical stimulation and chemical pharmaceuticals. However, these methods have their drawbacks. Chemicals are usually slow to take effect and have side effects, while electrical stimulation usually requires invasive wires, and is nearly impossible to administer within certain parts of the brain. Now, researchers at MIT and elsewhere have found a new method for stimulating neurons.

Read more Masimo Announces Bridge, A Wearable Neurostimulation Device That Reduces Opioid Withdrawal Symptoms

The finding might offer a step toward new kinds of therapeutic treatments, similar to electrically based neurostimulation that has been used to treat Parkinson’s disease and other conditions. Unlike those systems, which require an external wire connection, the new system would be completely contact-free after an initial injection of particles, and could be reactivated at will through an externally applied magnetic field, reports David L. Chandler at MIT News.

The researchers reported their finding in the journal ACS Nano.

“An interesting thing about the nervous system is that neurons can actually detect forces,” says MIT postdoc Alexander Senko PhD. “That’s how your sense of touch works, and also your sense of hearing and balance.” The team targeted a particular group of neurons within a structure known as the dorsal root ganglion, which forms an interface between the central and peripheral nervous systems, because these cells are particularly sensitive to mechanical forces.

The key to the new process was developing minuscule discs with an unusual magnetic property, which can cause them to start fluttering when subjected to a certain kind of varying magnetic field. These discs, which are hundreds of nanometers in diameter, contain a vortex configuration of atomic spins when there are no external magnetic fields applied. This makes the particles behave as if they were not magnetic at all, making them exceptionally stable in solutions. When these discs are subjected to a very weak varying magnetic field of a few millitesla, with a low frequency of just several hertz, they switch to a state where the internal spins are all aligned in the disc plane. This allows these nanodiscs to act as levers — wiggling up and down with the direction of the field, the MIT report said.

Read more This Wearable Device Can Improve Speech of People Living with Parkinson’s Disease

The work is still in its infancy, said Polina Anikeeva, an associate professor in the departments of Materials Science and Engineering and Brain and Cognitive Sciences. “This is a very first demonstration that it is possible to use these particles to transduce large forces to membranes of neurons in order to stimulate them.”

Text Link

How Health Technology Is Transforming The Lives Of Women Across The Globe

Innovations in health tech are changing the way people access healthcare

Innovations in health tech are changing the way people access healthcare. At the same time these innovations are enabling people to learn more about their bodies.

Read more Femtech Startup Bloomer Develops Smart Bra that Can Monitor Women’s Health

Women, in particular, are benefiting from health tech innovations as this group is worse affected by the limitations of health and sex education, reports MobiHealthNews.

Women make up about half (49%) of the world’s population. Statistics show that women live longer than men, but they may spend a greater part of their lives in poor health for various reasons. In the developing world, pregnancy and childbirth take a heavy toll on women’s health. Worldwide, nearly 380,000 women die from preventable causes related to pregnancy each year.

From wearable breast pumps to digital birth control, the Femtech market is gearing up to see an unprecedented wave of innovation.

Dr Deborah Maufi, a project manager at the Health[e]Foundation, saw the harm of ignorance and misinformation firsthand in her native Tanzania.

“It made me really aware…that a lot of educated women also don’t know [about their reproductive rights]. Now imagine those who are not educated at all,” Maufi said. In response, she developed an app called MyHealth@Hand. Using the app, pregnant women in Sub-Saharan Africa can connect with healthcare workers. “They can share health data and also the woman has access to health information about pregnancy and the newborn and can also chat to the healthcare professional in the app,” she said.

Read more How Femtech Companies are Helping to Make Women’s Lives Easier and More Comfortable

The Femtech market could appeal to women of all ages, races and nationalities. Innovations in this field aren’t only making it possible for women to manage their health on a more personalized level, but it is enabling them to learn more about their own health.

The key benefit of combining education with the digital is its accessibility. “Almost everything that we do now is digital,” comments Dr. Maufi. “Even in developing countries: you see the economy's very low, but people still have access to smartphones.”

Text Link

Vitls Wins FDA Clearance For Its Remote Patient Monitoring Platform

Houston, Texas-based Vitls Inc. won FDA 510(k) clearance for its Vitls Platform

Houston, Texas-based Vitls Inc. won FDA 510(k) clearance for its Vitls Platform. The Vitls Platform is a combination of a vitals monitoring patch, cloud storage, and an app that lets clinicians monitor patients in multiple healthcare settings – from the hospital to the home.

Read more Abbott Receives FDA Approval for Gallant Heart Rhythm Implants Featuring Continuous Remote Monitoring

"Obtaining and managing patient vitals in a distributed environment can be challenging. The Vitls Platform, with its wearable device and accompanying software, offers a better chance for continuous, unobtrusive, remote monitoring, to better manage patient care in a multitude of scenarios,” said Stephen Meyer, former president & chief executive officer of Welch Allyn, reports BusinessWire.

Vitls developed a clinical-grade platform that enables healthcare providers to reliably and accurately monitor key patient vital signs in real-time. The Vitls Platform consists of Tégo, a small and unobtrusive wearable that wirelessly records vital signs; the Vitls Cloud, where data is stored and then sent to hospital systems, the Vitls App and other connected devices; and the Vitls App, which displays the data in an intuitive layout.

Data collected with the Vitls Platform gives healthcare providers a complete picture of a patient’s status, paving the way for early intervention and improved outcomes. Studies show that deterioration can be identified and treated more than 60 percent earlier with continuous, remote monitoring.

“When my eldest son suffered from febrile seizures, we couldn’t find anything reliable and accurate enough to alert us at the onset of his fevers; we developed Tégo to address the challenge of intermittent monitoring and late detection for both patients and clinicians,” said Werner Vorster, chief executive officer and founder of Vitls Inc. “With this FDA clearance and our US launch planned for Q3/2020, we are much closer to our goal of making continuous monitoring the standard of care in healthcare settings, as well as in the home. Healthcare needs accurate, clinical grade, continuous monitoring - especially now during COVID-19 - and we’re proud and fortunate to be in a position to help.”

Read more Medtronic Wins FDA Clearance And CE Approval For LINQ II Insertable Cardiac Monitor

Vitls Inc. is a digital healthcare company that focuses on remote monitoring of patient vital signs throughout the care continuum. The company developed the Vitls Platform which consists of the Tégo wearable, an unobtrusive patch that continuously collects vital signs and other data from the wearer, the Vitls Cloud, and the Vitls App.

Text Link

Needle-Free CGM Startup Movano Exits Stealth Mode And Raises $10M In A Bridge Round

health-focused technology company dedicated to enhancing the quality of life for people affected

Movano Inc., a health-focused technology company dedicated to enhancing the quality of life for people affected by chronic health conditions, has raised $10M in a bridge round led by Tri-Valley Ventures. Taken alongside its prior investments, the company said it has now raised $27 million since its founding in 2018. The company said it will use the money to develop its first product – a wearable, non-invasive continuous glucose monitor (CGM) powered by Radio Frequency (RF) technology that is painless, smart and simple.

Read more Dexcom G6 Pro CGM Offers Both Blinded And Unblinded Mode For Glucose Monitoring

According to the World Health Organization (WHO), the number of people with diabetes worldwide rose from 108 million in 1980 to 422 million in 2014. Without proper management diabetes can lead to heart disease, kidney failure and other serious health complications. Despite the prevalence of diabetes, only a small number of people with diabetes use a CGM today, primarily due to affordability.

“There’s a considerable disconnect between the demand for an inconspicuous and inexpensive glucose measurement solution and what’s on the market. Today, people with diabetes have two options to get a glucose reading - either prick their finger daily or wear an expensive, disposable patch,” said Michael Leabman, founder and CEO of Movano. “We plan to bridge this gap, so that measuring your glucose becomes as simple as glancing at your wrist, whether you’re a person with diabetes, pre-diabetes or a part of the greater wellness community.  We’re going to break down the current cost, usability and accessibility barriers with CGMs so that anyone can manage their glucose levels with confidence and in a way that best suits their lifestyle.”

Movano’s novel approach to glucose monitoring is centered around its patent-pending RF solution, which can be embedded in a wearable and connected to apps and the cloud. The combination of custom-built, miniature and highly flexible sensors, smart antennas and proprietary machine learning algorithms will form a glucose monitoring system that is more affordable and smaller in size than competing CGMs, reports GlobeNewsWire.

The company’s cloud-based network app will give users real-time data, including trending lines and time-in-range information. This will enable data sharing with healthcare providers, caregivers and family to optimize care routines, reinforce positive behaviors and serve as a catalyst for long-term behavioral changes. Armed with real-time knowledge about how glucose levels impact a person’s overall well-being, Movano’s solution is being designed as a valuable preventative care tool to aid users in making data-driven decisions, reducing the frequency of doctor and hospital visits.

Read more Abbott’s Freestyle Libre 2 iCGM Receives FDA Clearance For Adults And Children With Diabetes In The U.S.

“What makes a digital health tool effective is its ability to keep consumers engaged without disrupting their normal routine and a design that makes the wearer feel like a person, not a patient,” said Greg Hitchan, Managing Partner of Tri-Valley Ventures. “What resonated with us about Movano is its consumer-centric approach to glucose management. Its non-invasive solution, which can be included in wearable devices, enables users to get a continuous reading no matter where they are. With the potential to improve the quality of life for so many people dealing with serious health conditions related to diabetes, we see a bright future for Movano and its technology.”

Text Link

UnitedHealth Group Launches New Digital Therapy To Improve Lives Of People With Type 2 Diabetes

UnitedHealth Group has launched an innovative new therapy

UnitedHealth Group has launched an innovative new therapy that combines wearable technology and customized personal support to help improve the health of people living with type 2 diabetes.

The therapy — known as Level2 — helps eligible participants gain real-time insights about their condition and, for some, successfully reduce spikes in blood sugar levels or even achieve type 2 diabetes remission. Level2 equips eligible participants with integrated tools that include a mobile continuous glucose monitor (CGM), activity tracker, app-based alerts and one-on-one clinical coaching to help encourage healthier lifestyle decisions, such as food choices, exercise and sleep patterns. In the future, UnitedHealth Group may offer the Level2 model to support people with other chronic conditions beyond type 2 diabetes.

Read more Dexcom G6 Pro CGM Offers Both Blinded And Unblinded Mode For Glucose Monitoring

Level2 is available at no additional cost to more than 230,000 employer-sponsored, fully insured UnitedHealthcare members in 27 states and Washington, D.C.

Maintaining appropriate blood sugar levels, as measured by hemoglobin A1C, is a key focus for people with diabetes. In a pilot study of more than 790 UnitedHealthcare members, certain Level2 participants achieved a clinically meaningful reduction in their A1C within 90 days. Participants who began this therapy with the most significantly elevated A1C (above 8.0%) saw the greatest reduction (more than 1 percentage point decrease on average). By helping participants better control blood sugar levels and, in certain cases, achieve type 2 diabetes remission, some Level2 participants no longer require medication for their condition. To date, Level2 has helped participants improve their health to the degree they eliminated the need for more than 450 prescriptions, reports UnitedHealth Group.

“The combination of insights and resources in Level2 provides a high-touch, therapeutic benefit to help participants take charge of their type 2 diabetes and achieve better health,” said Amy Meister, D.O., CEO of Level2. “Connected devices such as continuous glucose monitors and activity trackers may be game-changers for the approximately 30 million people2 nationwide living with type 2 diabetes. By expanding this innovative new therapy to more members across the country, we are empowering people with actionable information and personalized support.”

Initial studies show that sudden changes in blood sugar levels among people with type 2 diabetes may indicate potential COVID-19 infections. Closely monitoring this metric among Level2 participants and supporting people at greater risk for COVID-19 complications, Level2 has demonstrated the ability to predict potential COVID-19 infections and help encourage access to needed medical care earlier. Type 2 diabetes may be a risk factor associated with worse outcomes related to COVID-19.3 However, people with type 2 diabetes whose blood sugar is stable may experience fewer medical complications and greater likelihood of recovery from COVID-19.

Read more Innovosens’ Diabetes Monitoring Technology May Help In Early Detection Of COVID-19

Level2 is part of UnitedHealth Group’s industry-leading focus on integrating human support with advanced data analytics, including from real-time sources such as digital health technologies, to help improve and personalize therapies.

Level2 will be made available to select employers with self-funded plans later this year.

Text Link

Wearables Playing Crucial Role In Patient Monitoring During COVID-19 Pandemic

Wearable technologies can be innovative solutions for healthcare problems

Wearable technologies can be innovative solutions for healthcare problems. According to a literature review of wearable technology applications by Healthcare Information and Management Systems Society, Inc. (HIMSS), wearable applications can directly impact clinical decision making. Wearable technologies enable the continuous monitoring of human physical activities and behaviors, as well as physiological and biochemical parameters during daily life. The most commonly measured data include vital signs such as heart rate, blood pressure, and body temperature, as well as blood oxygen saturation, posture, and physical activities through the use of electrocardiogram (ECG), ballistocardiogram (BCG) and other devices.

Read more Thinklabs One Electronic Stethoscope Keeping Healthcare Professionals Safe During COVID-19 Pandemic

Wearable technology is playing a crucial role during the current pandemic. For example, according to Harvard University, Edmond J. Safra Center for Ethics, in March 2020, the South Korean government implemented a smartphone app to supervise the self-quarantine of those who met criteria for confirmed contact with individuals who were confirmed to have the viral infection, according to news provided by FinancialBuzz.com.

Nemaura Medical, Inc. announced earlier last week breaking news that it has, "issued a presentation outlining potential new applications for monitoring disease progression in Covid-19 patients using Continuous Lactate Monitoring (CLM). The company’s both CGM and CLM products are based on Nemaura's BEAT platform, which is designed to non-invasively extract a number of analytes through the skin. By adapting the sensor chemistry, algorithm and mobile app interface initially developed for sugarBEAT, the BEAT platform has the potential to be utilized for several markets beyond glucose monitoring and diabetes. Nemaura is evaluating the timelines for bringing the CLM to market as a Class 2 approved Medical Device.

OPKO Health, Inc. announced earlier this month that it will conduct COVID-19 testing for all Major League Soccer (MLS) players as well as match officials, and Club and League staff participating in the MLS is Back Tournament. MLS has chosen BioReference as its laboratory to assist in informing its return-to-play policies for the Tournament kicking off in Orlando in early July.

Moderna, Inc. announced last week the publication of an interim analysis of the open-label Phase 1 study of mRNA-1273, its vaccine candidate against COVID-19, in The New England Journal of Medicine. This interim analysis evaluated a two-dose vaccination schedule of mRNA-1273 given 28 days apart across three dose levels (25, 100, 250 µg) in 45 healthy adult participants ages 18-55 years, and reports results through Day 57.

Koninklijke Philips N.V. reported earlier this month that it had introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India. Designed to meet the critical-care requirements of patients, each prefabricated ICU has a capacity of nine beds. The units will be locally manufactured by Philips in India, with each ICU unit capable of being deployed in one day. India is in the top 5 countries with the highest amount of COVID-19 cases. The country's healthcare system is under immense pressure as infections spike. Leveraging its clinical, technical and design expertise, Philips has developed new mobile ICUs to address the challenging needs of critical-care services in India.

Read more BHP Trials Wearable Technology On Its Iron Ore Mines During COVID-19

iBio, Inc. announced back in June that IBM Watson Health had selected iBio to receive 18 months of use of the IBM Clinical Development (ICD) solution, free-of-charge. IBM Watson Health recently began offering its ICD solution to eligible trial sponsor organizations as part of its efforts to help support the medical community to address the COVID-19 pandemic. IBM Watson Health has received interest in the offering from numerous hospitals, sponsors, contract research organizations and academic institutions, and is currently enabling 15 COVID-19 disease trials.

Text Link

Fitness App Market Poised To Grow at a CAGR of 12%, Reaching 1.68 Billion During 2020-2024 Period

the fitness app market is poised to grow by USD 1.68 billion during 2020-2024

According to a new report by Technavio, the fitness app market is poised to grow by USD 1.68 billion during 2020-2024, progressing at a CAGR of 12% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Read more Global E-compass Market Is Expected To Grow At A CAGR of 14% From 2019 to 2024

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities, reports BusinessWire.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. adidas AG, ASICS Digital Inc., Azumio Inc., BetterME., FitNow Inc., Google LLC, Nike Inc., Samsung Electronics Co. Ltd., Under Armour Inc., and YAZIO GmbH are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments, the Technavio report said.

Increasing demand for wearable devices has been instrumental in driving the growth of the market.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Fitness App Market is segmented as below:

Gender

  • Female
  • Male

Application

  • Lifestyle Monitoring
  • Health Monitoring
  • Others

Geographic Landscape

  • APAC
  • North America
  • Europe
  • South America
  • MEA

Fitness App Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The fitness app market report covers the following areas:

  • Fitness App Market Size
  • Fitness App Market Trends
  • Fitness App Market Analysis

This study identifies the proliferation of a variety of fitness apps as one of the prime reasons driving the fitness app market growth during the next few years.

Read more Global Blockchain IoT Market Expected To Grow At A CAGR of 44.83% To $2,389 Million By 2025

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Vendor Analysis

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • adidas AG
  • ASICS Digital Inc.
  • Azumio Inc.
  • FitNow Inc.
  • Google LLC
  • Nike Inc.
  • Samsung Electronics Co. Ltd.
  • Under Armour Inc.
  • YAZIO GmbH

Text Link

Medtronic Wins FDA Clearance And CE Approval For LINQ II Insertable Cardiac Monitor

announced it has received U.S. FDA clearance and European CE Mark approval

Medtronic, the global leader in medical technology, announced it has received U.S. FDA clearance and European CE Mark approval for its LINQ II insertable cardiac monitor (ICM) with remote programming, which enables clinicians to optimize device settings without the need for patients to return to the office or hospital. The LINQ II system also delivers improved device longevity (4.5 years*1) compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients.

Read more Medtronic Buys Diabetes Management Startup Klue to Strengthen Personalized Closed Loop System

LINQ II is a small (one-third the size of a AAA battery), wireless ICM for patients with abnormal heart rhythms who experience infrequent symptoms including dizziness, palpitations, syncope (fainting) and chest pain, thereby requiring long-term monitoring or ongoing management. The device will be commercially available in the U.S. and Europe later this summer, reports Medtronic.

“In the current COVID-19 environment, the LINQ II system offers patients a seamless way to experience ongoing connectivity between their device and their physician, while reducing the need for in-office visits,” said Rob Kowal, M.D., Ph.D., chief medical officer of the Cardiac Rhythm and Heart Failure division, which is part of the Cardiac and Vascular Group at Medtronic. “LINQ II gives physicians actionable data to help diagnose underlying heart conditions and define treatment protocols for patients with atrial fibrillation (AF) or other abnormal heart rhythms.”

The LINQ II device incorporates many of the features of LINQ with TruRhythm plus improvements that differentiate the device from other ICMs:

  • Accuracy and Streamlined Workflows. The LINQ II device has the lowest published rates of AF false detections compared to previous ICMs.2-5 It also has an industry-exclusive Premature Ventricular Contraction (PVC) detector to help with patient diagnosis; PVCs are extra, abnormal heartbeats that begin in the ventricles, and disrupt the heart rhythm. Additionally, clinicians spend 33 percent less time reviewing ICM transmissions,6 resulting in potential office efficiencies and reduced costs due to more streamlined workflows.
  • Remote Programming. The LINQ II ICM offers remote programming, which reduces the need for patients to come into the office to have their device settings adjusted – a benefit for both patients and physicians, especially during the current COVID-19 pandemic.
  • Remote Patient Management. Patients with the LINQ II ICM can choose one of two monitoring options to fit their lifestyles and increase remote monitoring compliance, potentially leading to improved patient outcomes:
    • Patients can use their smartphones to automatically transfer device data via the MyCareLink Heart™ mobile app using BlueSync™ technology that enables secure communication via Bluetooth.
    • Patients who are unable or prefer not to use a cell phone can transmit device data with the MyCareLink Relay™ Home Communicator.
  • Increased Longevity. The LINQ II device offers an extended duration of continuous monitoring at 4.5 years*1. Continuous monitoring gives physicians greater insights into patient data, aids in diagnoses and helps them manage chronic cardiac arrhythmias.

Read more Medtronic Receives CE Mark For Its MiniMed 780G Insulin Pump With Artificial Pancreas Capabilities

In collaboration with leading clinicians, researchers and scientists worldwide, Medtronic offers the broadest range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias.

Text Link

WT | Studio Talk: Lifesense and Fizimed - Wearables for Women´s Health

Want to learn how Wearables can increase Women´s Health? Wait no further! Listen to Julia van Zante

Want to learn how Wearables can increase Women´s Health?

Wait no further! Listen to Julia van Zanten, Chief Product Officer at Lifesense Group (Chapter 2: 33:00 min. in the Webinar) as well as to Emeline Hahn, CEO of Fizimed (Chapter 1: at 21:00 min. in the Webinar)!

Watch the whole WT | Webinar "Wearables for Women's Health" here:

https://vimeo.com/438213195/5106d67e6a

Do you have a question to the Speaker? Place your question here:

Text Link

HandsFree Health Files Patent For Secure and Personalized Health Experience For Users

HandsFree Health, well-known for its WellBe, a secure, HIPAA compliant, voice-enabled

HandsFree Health, well-known for its WellBe, a secure, HIPAA compliant, voice-enabled virtual health assistant platform, announced the company has filed a new patent to add to its technology portfolio. The patent-pending technology identifies individuals within a household so that each person has a secure and personalized health experience within the HandsFree Health platform.

Read more Orbita Launches AI-Powered Virtual Bedside Assistant To Improve Patient Care

“Our new patent-pending technology provides layers of security for WellBe smart speaker users to ensure that their interactions with the voice technology device will be unique to them," said Dan Messina, Co-Founder, HandsFree Health. “This new patent uses a series of security components to not only identify household members, but also provide them with a unique and personalized voice technology experience based on their own health and wellness preferences."

This new patent filed covers a variety of technology features in the HandsFree Health WellBe device that allow each family member to have a secure experience. The individualized support includes personalized care, appointment and medication reminders, and different colored lights for each family member who is interacting with the WellBe smart speaker. This latest patent builds on the HandsFree Health patent portfolio which also includes patent-pending technology which allows remote setup of the HandsFree Health platform from anywhere in the U.S, says a press release.

HandsFree Health's HIPAA-compliant, proprietary product offerings for the healthcare market include a voice assistant, mobile applications, and wearable devices. The devices will be sold on the HandsFree Health website as well as major retailers later this month.

Read more Apple Announces Airpods 2 with Voice Control and Optional Wireless Charging

HandsFree Health was recently featured at VOICE Global Summit, a worldwide conference highlighting leaders in voice technology. HandsFree Health's Co-Founder was also named a PM360 ELITE winner (Exceptional-Leaders-Innovators-Transformers-Entrepreneurs), as one of the 100 most influential people in the healthcare industry. Employee Benefit News and Employee Benefit Adviser awarded HandsFree Health's Co-Founder with a 2019 Digital Innovator Award for WellBe. HandsFree Health was also featured at Microsoft Build 2019 demonstrating artificial intelligence integration for the healthcare market.

Text Link

MU Engineers Develop New Method Of Allowing Patients To Draw Their Biomedical Sensors On Skin

Some of the most widely used wearable devices are applications for assessing and monitoring

Some of the most widely used wearable devices are applications for assessing and monitoring vital signs. However, they are typically complex devices and tend to be expensive and fragile. Now, researchers at the University of Missouri have invented a method of using simple graphite pencils and paper to create highly functional bioelectronic devices.

Read more Graz University Researchers Develop Tattoo Electrodes For Long-Term EEG Brain Monitoring

The researchers said their discovery could have broad future applications in home-based, personalized health care, education and remote scientific research such as during the COVID-19 pandemic.

Their findings are published in the journal Proceedings of the National Academy of Sciences.

Zheng Yan, an assistant professor in the College of Engineering, said many existing commercial on-skin biomedical devices often contain two major components — a biomedical tracking component and a surrounding flexible material, such as plastic, to provide a supportive structure for the component to maintain an on-skin connection with a person’s body, reports Eric Stann in Mizzou News.

“The conventional approach for developing an on-skin biomedical electronic device is usually complex and often expensive to produce,” he said. “In contrast, our approach is low-cost and very simple. We can make a similar device using widely available pencils and paper.”

Leads in the pencil are made of various levels of graphite, clay and wax. Since their invention, they’ve been used for writing and drawing. In this new study, the researchers discovered that pencils containing more than 90% graphite are able to conduct a high amount of energy created from the friction between paper and pencil caused by drawing or writing. Specifically, the researchers found pencils with 93% graphite were the best for creating a variety of on-skin bioelectronic devices drawn on commercial office copy paper. Yan said a biocompatible spray-on adhesive could also be applied to the paper to help it stick better to a person’s skin. He said their next step would be to further develop and test the use of the biomedical components, including electrophysiological, temperature and biochemical sensors.

Read more New Stretchable E-Tattoo for Long-Term Uninterrupted Heart Monitoring

“For example, if a person has a sleep issue, we could draw a biomedical device that could help monitor that person’s sleep levels,” he said. “Or in the classroom, a teacher could engage students by incorporating the creation of a wearable device using pencils and paper into a lesson plan. Furthermore, this low-cost, easily customizable approach could allow scientists to conduct research at home, such as during a pandemic.”

An additional benefit to their approach, Yan said, is that paper can decompose in about a week, compared to many commercial devices that contain components that are not easily broken down.

Text Link

BHP Trials Wearable Technology On Its Iron Ore Mines During COVID-19

BHP said cutting edge wearable technology is enabling its teams in Perth

BHP said cutting edge wearable technology is enabling its teams in Perth to remotely assist auto electricians’ and mechanical fitters remotely. The company used mixed-reality (MR) like the Microsoft HoloLens to link its teams in Australia with auto electricians and mechanical fitters on-site from 1,300 kilometers away.

Related NexTech AR Inks Deal with Romios Gold to Bring 3D Augmented Reality Solution to the Mining Sector

“When COVID-19 struck, our teams couldn’t travel from Perth to our sites in Western Australia,” said Alex Bertram, Manager Digital Transformation in WAIO. “So we improvised. In mining, people FIFO (fly-in, fly-out). Some DIDO (drive-in, drive-out). Soon our teams will be able to RiRo – which stands for Remote-In Remote-Out. RiRo is essentially our teams providing remote assistance via live point of view video calls to our personnel on site.”

According to Bertram, the teams could soon start a new travel arrangement termed as remote-in, remote out (RiRo). With RiRo, teams can provide remote assistance via live point of view video calls to BHP personnel on-site, reports SafeToWork.

"RiRo…[allows] BHP engineers, integrated planning and remote operations (IPRO) operators and technical experts in Perth, in site offices or anywhere in the world to see exactly what people in the field see, in real-time,” said Cristina Perbellini Silva, who serves as the manager of decision automation in technology.

BHP’s team of technicians used cloud services and a headset device to call for help and support when needed, such as for complex tasks. BHP has a very high-performance rate at its Western Australian Iron Ore division operations, leaving little room for downtime, Bertram said.

“Utilizing cloud services and a mixed reality headset device, our technicians on the frontline can call for help and technical support when they need it most – during critical breakdowns and when undertaking new or complex tasks,” Bertram said.

"This approach is essentially our teams providing remote assistance via live-point-of-view video calls to our personnel on-site.”

Related Smart Equipment to Enable Hands-Free Mining in the Future

BHP Minerals Australia vice president of technology, Pat Bourke said:

“Remote work using technology was always an option for us, however, COVID-19 has pushed us to really harness innovative technology and we will only continue to improve our productivity as we make it widely available and perfect its use.”

Text Link

Thinklabs One Electronic Stethoscope Keeping Healthcare Professionals Safe During COVID-19 Pandemic

To stay safe during the COVID-19 pandemic many healthcare companies are implementing telehealth

To stay safe during the COVID-19 pandemic many healthcare companies are implementing telehealth and telemedicine platforms and wearable devices that allow remote patient monitoring. Now, Thinklabs One announced the launch of its electronic stethoscope that helps keep healthcare workers safe during the COVID-19 pandemic by allowing Safe Distance Auscultation. This is the process by which doctors can listen to patients' hearts and lungs while wearing personal protective equipment (PPE) or from a safe distance with the use of external speakers, or earbuds.

Read more KYOCERA and TMDU Join Forces To Develop Wearable for Remote Rehab Monitoring During COVID-19 Pandemic

Thinklabs One helps doctors listen to patients' heart and lungs, which is imperative to a doctor's ability to treat patients, particularly those affected by COVID-19. Currently in use at prestigious medical facilities including Johns Hopkins, Mount Sinai, and St. Jude Children's Research Hospital, the Thinklabs One features more than 100X amplification, as compared to a traditional acoustic stethoscope, says a press release.

Conventional stethoscopes with rubber tubing are not compatible with layers of PPE. The Thinklabs One has no tubing—just a universal size jack that can connect to speakers, headphones, or a Bluetooth transmitter to listen from a distance. This makes it easier to listen to patients' lungs over the noise caused by the filtration and purification systems in some PPE, or to set up telemedicine systems to listen to patients in separate rooms. The Thinklabs One is used extensively in telemedicine practices, and Thinklabs has created partnerships with key video conferencing providers including Zoom, Vidyo, Vsee, and others to provide best-in-class telemedicine capabilities with the device.

Thinklabs One supported doctors during the Ebola epidemic in Africa and at hospitals that were on the frontline in the U.S., including Bellevue Hospital Center in New York, the Nebraska Medical Center, and Emory Healthcare in Atlanta.

Read more Elektra Labs Introduces Free Platform For Clinicians And Researchers In The Fight Against COVID-19

“For more than 25 years, we have developed and manufactured electronic stethoscopes to improve the detection and diagnosis of disease and save patients' lives. Within one week in March, COVID-19 placed a new demand on our device: to save doctors' lives," said Clive Smith, CEO and founder of Thinklabs. "Like other medical device manufacturers, we saw a step-change in demand. Like doctors and nurses on the frontlines, we had to innovate in real-time, to accommodate entirely new use cases, such as doctors who wanted to listen from 25 feet away to patients who might be sitting in their cars in a drive-through diagnostic or testing site.”

Text Link

VOS Systems Launches Contact Tracing Platform AlertTrace To Provide Precise COVID-19 Tracing For Employees

VOS Systems has launched AlertTrace, an anonymous contact tracing solution

VOS Systems has launched AlertTrace, an anonymous contact tracing solution for workplace safety. VOS is a joint venture of three leading U.S. technology companies: VOLT Wearable Tech, Ottogee and Scout IoT. AlertTrace provides reliable daily monitoring to record close contact interactions through wearable Bluetooth technology, then uploads interaction data with end-to-end encryption for ensured privacy and anonymity. Through the use of AlertTrace, organizations are able to react quickly and accurately to safeguard employees that may be at risk of contracting COVID-19 in the workplace.

Read more btwTAG Contact Tracing Solution Now Available For US, Europe, South American Companies

“The pen and paper method of contact tracing is cumbersome, time-consuming and is difficult to deploy effectively on a large scale,” said James Davis, President of Scout IoT. “We knew we had to develop an automated way to collect and quickly analyze contact tracing data while avoiding the privacy concerns that come with phone apps.”

Manufactured in the United States, AlertTrace is unique in having been developed by engineers specifically for contact tracing. Its data collection with true military-grade block-chain security can quickly and effectively triage those with greater risk of developing COVID-19 symptoms while also providing insight for improvements in overall workplace safety. For instant data analysis, the AlertTrace administrator dashboard provides employers with analytics derived from the AI built into an advanced IoT platform. With seamless plug and play integration, AlertTrace can be deployed in a matter of hours, says a press release.

“Improving contact tracing should not be at the expense of invading people's privacy, location or personal phones and should not be driven by profits at a time when small and large companies are facing tremendous organizational and financial challenges,” said Omar Ghazzaoui, Founder of Ottogee, a Techstars backed company. “We made sure that Alert Trace aligns with those principles and this is what's driving adoption by government entities and fortune 1,000 companies.”

Read more EmbedTek’s PariRange Wearable Provides Peer-To-Peer Social Distancing And Contact Tracing

Currently, AlertTrace is being used in several federal pilot programs to proactively address the spread of COVID-19.

Text Link

June 2024: World's Most Accurate Hydration Sensor

To prevent cramps and collapses, the company FLOWBIO has launched its hydration sensor S1.
Text Link

May 2024: Innovation in the Fight Against Hearing Loss

Neosensory's Clarify - A breakthrough solution to improve hearing.
Text Link

April 2024: The Revolution Against Chronic Tremors

The GyroGlove revolutionizes the lives of many people suffering from tremors.
Text Link

March 2024: Revolution in Diabetes, Painless Smartpatch

Medicsen revolutionizes diabetes treatment with a painless Smartpatch.
Text Link

February 2024: Empowering Visually Impaired with GUIDI

AI Guided transforms lives with GUIDI, an advanced AI navigation companion.
Text Link

January 2024: Hydrogel-Free Flexcon® Omni-Wave™ for Biosensing

Dry electrode technology saves time and money for manufacturers while improving patient comfort!
Text Link

December 2023 : Flow Neuroscience

Flow: Home-based depression relief—fast, safe, innovative.
Text Link

November 2023: Linxens

Linxens Combines Skin Adhesive Technology and Biosensors for Cutting-Edge Medical Wearables.
Text Link

October 2023: LIFELEAF®

Discover how LIFEPLUS is reshaping health monitoring, offering real-time insights and fostering care
Text Link

September 2023: Frenz Brainband

Earable® Neuroscience´s Frenz Brainband: AI sleep & focus revolution.
Text Link

August 2023: Seismic

Seismic revolutionizes workplace safety and wellness with data-driven solutions.
Text Link

July 2023: VEMOTION

Technology that enhances early mobilization, a vital therapy in preventing adverse effects.
Text Link

June 2023: machineMD

machineMD's neurophthalmoscope: A game-changer in brain disorder detection.
Text Link

May 2023: The World's 1st Smart Wearable to Reverse Common Hair Loss

Niostem launches its hair regrowth wearable to combat pattern baldness in an Indiegogo campaign!
Text Link

April 2023: Bringing Vital Signs Monitoring into the Wearable Domain

EBV Elektronik presents key sensors for enabling vital sign sensing in wearables.
Text Link

March 2023: Implandata Ophthalmic Products GmbH

Leading the digital transformation of glaucoma care!
Text Link

February 2023: Leitwert

A Swiss-based start-up focusing on seamless device-to-cloud connectivity targeting multiple players.
Text Link

January 2023: Sony's mHealth Platform

Sony is stepping into the Wearable Market with their mSafety Platform.
Text Link

December 2022: Quad Industries

Screen-print electrodes and biosensors increase their scope of application!
Text Link

November 2022: MediBioSense Ltd.

Revolutionizing the Way Health Is Assessed, Tracked, and Treated!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.